Answer:
Volume 9A brings together general guidance on the requirements, procedures, roles and activities in the field of pharmacovigilance, for both Marketing Authorisation Holders (MAH) and Competent Authorities of medicinal products for human use; it incorporates international agreements reached within the framework of the International Conference on Harmonisation (ICH).
| Previous Question | Next Question |
| Explain me what Is An Adverse Drug Event (ade)? | Tell me when do you consider an event to be serious? |